Aug 9 (Reuters) - The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's (MRK.N), opens new tab diabetes drugs Januvia and Janumet, were ...
Merck stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth. The franchise made up 12% of Merck's sales in the first quarter and probably a larger ...
CHICAGO, June 23 (Reuters) - Merck & Co.'s new diabetes pill, Januvia, improved blood sugar control when added to current therapies, according to data released on Saturday at a major medical meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results